- Home
- IMNM vs WTFCM Comparison
IMNM vs WTFCM Comparison
Compare IMNM & WTFCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- WTFCM
- Stock Information
- Founded
- IMNM 2006
- WTFCM N/A
- Country
- IMNM United States
- WTFCM United States
- Employees
- IMNM N/A
- WTFCM 5521
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- WTFCM Major Banks
- Sector
- IMNM Health Care
- WTFCM Finance
- Exchange
- IMNM Nasdaq
- WTFCM Nasdaq
- Market Cap
- IMNM 747.7M
- WTFCM N/A
- IPO Year
- IMNM 2020
- WTFCM N/A
- Fundamental
- Price
- IMNM $10.25
- WTFCM $25.12
- Analyst Decision
- IMNM Strong Buy
- WTFCM
- Analyst Count
- IMNM 5
- WTFCM 0
- Target Price
- IMNM $28.60
- WTFCM N/A
- AVG Volume (30 Days)
- IMNM 856.1K
- WTFCM N/A
- Earning Date
- IMNM 11-13-2024
- WTFCM N/A
- Dividend Yield
- IMNM N/A
- WTFCM N/A
- EPS Growth
- IMNM N/A
- WTFCM N/A
- EPS
- IMNM N/A
- WTFCM N/A
- Revenue
- IMNM $10,129,000.00
- WTFCM N/A
- Revenue This Year
- IMNM N/A
- WTFCM N/A
- Revenue Next Year
- IMNM N/A
- WTFCM N/A
- P/E Ratio
- IMNM N/A
- WTFCM N/A
- Revenue Growth
- IMNM N/A
- WTFCM N/A
- 52 Week Low
- IMNM $8.97
- WTFCM N/A
- 52 Week High
- IMNM $30.96
- WTFCM N/A
- Technical
- Relative Strength Index (RSI)
- IMNM 34.53
- WTFCM 47.04
- Support Level
- IMNM $10.67
- WTFCM $24.89
- Resistance Level
- IMNM $11.28
- WTFCM $25.27
- Average True Range (ATR)
- IMNM 0.76
- WTFCM 0.08
- MACD
- IMNM -0.27
- WTFCM -0.01
- Stochastic Oscillator
- IMNM 0.63
- WTFCM 58.54
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About WTFCM Wintrust Financial Corporation Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series D
Wintrust Financial Corp is a financial holding company operating in the Chicago metropolitan area and southern Wisconsin through its wholly-owned banking subsidiaries. Wintrust conducts its business through three segments: community banking, specialty finance, and wealth management. Among other services, the company provides community-oriented, personal, and commercial banking, as well as the origination and purchase of residential mortgages for sale into the secondary market. A majority of its banks are banks chartered by the state of Illinois with scores of locations. The company has historically grown through both de novo organization and acquisitions. A majority of its loan portfolio is commercial, mostly in real estate. A majority of Wintrust's net revenue is net interest income.